Press Releases

Date Title and Summary Additional Formats
Toggle Summary CHF Solutions Announces Launch of Ultrafiltration Therapy Using Aquadex FlexFlow® System at Memphis Methodist Le Bonheur Healthcare System
EDEN PRAIRIE, Minn. , Dec. 03, 2019 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS) today announced that Memphis, Tennessee -based health system, Methodist Le Bonheur, has initiated offering aquapheresis therapy to patients suffering from fluid overload using the company’s Aquadex FlexFlow system.
View HTML
Toggle Summary CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
EDEN PRAIRIE, Minn. , Nov. 15, 2019 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ: CHFS), today announced that, on November 12, 2019 , the independent directors approved eight equity awards under CHF Solution’s New-Hire Equity Incentive Plan, as material inducements to eight individuals entering
View HTML
Toggle Summary CHF Solutions, Inc. Announces Third Quarter Financial Results and Provides Company Update
EDEN PRAIRIE, Minn. , Nov. 05, 2019 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq: CHFS), a medical device company focused on developing, manufacturing and commercializing a clinically proven solution for diuretic-resistant patients suffering from fluid overload, announced today its results for
View HTML
Toggle Summary CHF Solutions, Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market
EDEN PRAIRIE, Minn. , Nov. 04, 2019 (GLOBE NEWSWIRE) -- CHF Solutions , Inc. ( CHF Solutions or the Company) (NASDAQ:CHFS) today announced the pricing of a registered direct offering of 1,219,076 shares of its common stock (or common equivalents) at a price to the public of $1.12 per share, for
View HTML
Toggle Summary CHF Solutions, Inc. Announces Sales Force Realignment To Increase Focus On Cardiac Surgery And Eventually Pediatrics
EDEN PRAIRIE, Minn. , Nov. 01, 2019 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq: CHFS), a medical device company focused on developing, manufacturing and commercializing a clinically proven solution for diuretic-resistant patients suffering from fluid overload, announced a sales force
View HTML
Toggle Summary CHF Solutions, Inc. To Announce Third Quarter 2019 Financial Results and Corporate Update on November 5, 2019
EDEN PRAIRIE, Minn. , Oct. 29, 2019 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ: CHFS) announces today that its third quarter 2019 financial results will be released on Tuesday, November 5, 2019 . The company will host a conference call and webcast at 9:00 AM ET that morning, during which
View HTML
Toggle Summary Abington Hospital Begins a 344 Patient Retrospective Clinical Study to Analyze Experience with CHF Solutions’ Aquadex FlexFlow® System
EDEN PRAIRIE, Minn. , Oct. 24, 2019 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS) today announced that investigators at Abington Hospital-Jefferson Health in Abington, Pennsylvania are conducting a retrospective analysis of their experience using the company’s Aquadex FlexFlow System in heart
View HTML
Toggle Summary CHF Solutions, Inc. Announces Pricing of Registered Direct Offering
EDEN PRAIRIE, Minn. , Oct. 23, 2019 (GLOBE NEWSWIRE) -- CHF Solutions , Inc. ( CHF Solutions or the Company) (NASDAQ:CHFS) today announced the pricing of a registered direct offering of 575,830 shares of its common stock at a price to the public of $1.15 per share, for gross proceeds of
View HTML
Toggle Summary CHF Solutions to Exhibit at The American College of Chest Physicians (CHEST) Annual Meeting 2019
EDEN PRAIRIE, Minn. , Oct. 17, 2019 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq:CHFS) today announced that it will be exhibiting at the American College of Chest Physicians’ (CHEST) Annual Meeting 2019, on October 21-23, 2019 . The conference will be held at the Ernest N.
View HTML
Toggle Summary CHF Solutions Announces that James A. Haley Veterans’ Hospital Receives Final Approval To Initiate Heart Failure Outpatient Study utilizing Aquadex FlexFlow® System
First Study of Aquadex FlexFlow System Sponsored by United States Veterans Administration for Aquapheresis Treatment in Patients Suffering from Fluid Overload. First patient enrollment expected in the fourth quarter of 2019.   EDEN PRAIRIE, Minn. , Oct.
View HTML